A breath of pragmatism. Invited commentary on... Cardiovascular monitoring with acetylcholinesterase inhibitors

Advances in Psychiatric Treatment

Volumn 13, Issue 3, 2007, Pages 185-186

  Bullock, Roger ^a  

^a VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE;

ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COMPLETE HEART BLOCK; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HUMAN; INTERRATER RELIABILITY; PATIENT SAFETY; RISK REDUCTION; SCREENING; SECOND DEGREE ATRIOVENTRICULAR BLOCK;

EID: 38549168581     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.107.003574     Document Type: Article

References (2)

1. Ariyarajah, V., Asad, N., Tandar, A., et al (2005) Interatrial block: pandemic prevalence, significance, and diagnosis. Chest, 128, 970-975
2. Rowland, J. P., Rigby, J., Harper, A. C. & Rowland, R. (2007) Cardiovascular monitoring with acetylcholinesterase inhibitors: a clinical protocol. Advances in Psychiatric Treatment, 13, 178-184.